Harvard Bioscience Stock Forecast
NASDAQ: HBIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
HBIO analyst consensus
Consensus (2 analysts)
none
Avg. price target
$7.50-8.98%
- Strong buy 1
- Buy 0
- Hold 1
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 2 Wall Street analysts covering Harvard Bioscience (2026-10-09), 1 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $7.50, with a high estimate of $7.50 and a low estimate of $7.50. The average target implies downside of 9.0% from the current price of $8.24.
The spread between the highest and lowest targets is 0.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for HBIO.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 50% |
| Buy | 0 | 0% |
| Hold | 1 | 50% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $7.50 | -8.98% |
| Average target | $7.50 | -8.98% |
| High target | $7.50 | -8.98% |